ASSET SALE TO HEALGEN (Details Narrative)	12 Months Ended
	Dec. 31, 2022 USD ($)
ASSET SALE TO HEALGEN
Purchase price retention fund to cover potential indemnification claims	$ 300,000
Total consideration for sale of assets	3,000,000
Advances purchase price	715,000
Hold back purchase price amount	300,000
Remaining purchase price, amount	$ 2,700,000